24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Pfizer
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
16:00
Wix acquires Hour One, accelerating its push into AI-powered digital experiences
17:33
Full list of Israeli startup M&As in 2025
17:24
Fortinet acquires Israeli cyber startup Suridata for tens of millions to boost SaaS protection
17:03
Full list of Israeli high-tech funding rounds in 2025
More stories
Buzz
Most popular
Daily
Weekly
1
Fortinet acquires Israeli cyber startup Suridata for tens of millions to boost SaaS protection
2
Wix acquires Hour One, accelerating its push into AI-powered digital experiences
3
Gigi Levy-Weiss and Redis co-founder Yiftach Shoolman launch defense tech startup Line 5, raising $20M Seed round
4
Intel considering selling off networking business in strategic overhaul
5
Michael Levitt Analysis: Corona Is Slowing Down, Humanity Will Survive
More news
Pfizer
11 stories about Pfizer
First Pfizer Covid-19 vaccines land in Israel, Netanyahu plans to be first to receive it
09.12.20
|
Reuters
Israel plans to start administering the doses on Dec. 20, distributor Teva Pharmaceutical Industries said
Mega-cap tech firms could lag the market next year, but tech in general won't underperform, says UBS chief investment officer
06.12.20
|
Sophie Shulman
Mark Haefele, Chief Investment Officer at UBS Global Wealth Management, says that stock markets will rise and fall depending on how quickly Covid-19 vaccines are approved and distributed
“Excessive regulation” to blame for delay in Israeli Covid-19 vaccine says professor in charge
30.11.20
|
CTech
Director of the Israel Institute for Biological Research says vaccines will be distributed in the summer of 2021
New innovative vaccines by Moderna and Pfizer are safe, says top Israeli virologist
24.11.20
|
Yafit Ovadia
“There isn’t any need for alarm,” says virologist about new coronavirus vaccines
After a coronavirus vaccine is approved, what happens next?
22.11.20
|
Sophie Shulman
On Dec. 10, the FDA is expected to announce whether it will approve Pfizer’s new vaccine, but 2 trillion people will not receive it until the end of 2021
Markets may recover from pandemic soon, says CapitalG investor
17.11.20
|
CTech
Vaccine announcements, possible removal of U.S. travel ban and other factors will contribute to economic recovery, senior investors say in Calcalist and CTech’s Mind the Tech virtual conference
Moderna’s chief scientist says company initiated vaccine deal with Israel
16.11.20
|
Sophie Shulman
Israeli scientist Tal Zaks says Israel will be among the first to receive doses from the company’s European plant
Pfizer and BioNTech claim 90% effective rate for their Covid-19 vaccine
09.11.20
|
Reuters
The news comes at the same time that Israel is currently undergoing human trials of its own vaccine for deployment in 2021
As the Covid-19 vaccine arms race intensifies, big money is at risk
10.08.20
|
Sophie Shulman
Governments want to be among the first to get their hands on the coveted solution, but they are also risking money that could be used to strengthen their healthcare system
Place your bets: Which company will reach a Covid-19 vaccine first?
02.08.20
|
Sophie Shulman
Moderna may be creating all the buzz, but it is the youngest and least experienced of the contestants, playing an all or nothing game
Pfizer Taps Israeli Machine Learning Drug Discovery Company CytoReason
10.01.19
|
Lilach Baumer
Under the agreement, CytoReason will receive payments "potentially equaling up to low double digit millions" of dollars
Previous Articles
